Difference between revisions of "Team:UNITN-Trento/Results"

m
m
Line 50: Line 50:
 
 
 
 
 
<div class="row" >
 
<div class="row" >
<div class="6u 12u(narrower)  wow bounceInLeft">
+
<div class="6u 12u(narrower)  wow bounceInLeft" style="visibility:hidden;">
 
<h4 class="header4 wow fadeInDown      delay05"><span>Increasing the levels of NADH</span> <i class="faabig flaticon-speedometer26"></i></h4>  
 
<h4 class="header4 wow fadeInDown      delay05"><span>Increasing the levels of NADH</span> <i class="faabig flaticon-speedometer26"></i></h4>  
 
 
Line 61: Line 61:
 
</div>  
 
</div>  
 
 
<div class="6u 12u(narrower) wow bounceInRight">
+
<div class="6u 12u(narrower) wow bounceInRight" style="visibility:hidden;">
 
<h4 class="header4 wow fadeInDown delay05"> <span>PncB is not toxic if overexpressed in <span style="font-style:italic">E.coli</span></span> <i class="faabig flaticon-shield114"></i></h4>
 
<h4 class="header4 wow fadeInDown delay05"> <span>PncB is not toxic if overexpressed in <span style="font-style:italic">E.coli</span></span> <i class="faabig flaticon-shield114"></i></h4>
 
<p style="clear:both;">
 
<p style="clear:both;">
Line 78: Line 78:
 
<div class="row">  
 
<div class="row">  
 
<div class="12u 12u(narrower)">
 
<div class="12u 12u(narrower)">
<h4 class="header4 wow fadeInDown     delay05"> <span>PncB enhances NAD production by ~2.5 fold</span><i class="faabig flaticon-bars-graphic"></i></h4>
+
<h4 class="header4 wow fadeInDown   delay05" style="visibility:hidden;"> <span>PncB enhances NAD production by ~2.5 fold</span><i class="faabig flaticon-bars-graphic"></i></h4>
 
</div>
 
</div>
 
</div>
 
</div>
Line 87: Line 87:
 
 
 
<div class="row">  
 
<div class="row">  
<div class="7u 12u(narrower) wow bounceInLeft centered">
+
<div class="7u 12u(narrower) wow bounceInLeft centered" style="visibility:hidden;">
 
<p style="text-align:center;">
 
<p style="text-align:center;">
 
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/4/45/Unitn_pics_pncb_StarndarRatioPncB.png"  ><img src="https://static.igem.org/mediawiki/2015/5/5e/Unitn_pics_pncb_StarndarRatioPncB_thumb.png" alt="" style="width:100%; max-width:700px;"/></a>
 
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/4/45/Unitn_pics_pncb_StarndarRatioPncB.png"  ><img src="https://static.igem.org/mediawiki/2015/5/5e/Unitn_pics_pncb_StarndarRatioPncB_thumb.png" alt="" style="width:100%; max-width:700px;"/></a>
Line 93: Line 93:
 
</div>
 
</div>
 
 
<div class="5u 12u(narrower) wow bounceInRight">
+
<div class="5u 12u(narrower) wow bounceInRight" style="visibility:hidden;">
 
<p class="image_caption" style="clear:both;"><span>__Title of the Figure__</span> NAD and NADH levels were quantified with Sigma NAD /NADH quantification kit (MAK037)  following the instructions described in the technical bulletin. Panel A: Standard curve (0, 20, 40, 60,  80, 100 pmole/well of NADH)). Panel B: NAD/NADH levels for three biological samples of  BBa_K1604030 (green) and one negative control BBa_K731201 (blue). The cells were grown as described previously.</p>
 
<p class="image_caption" style="clear:both;"><span>__Title of the Figure__</span> NAD and NADH levels were quantified with Sigma NAD /NADH quantification kit (MAK037)  following the instructions described in the technical bulletin. Panel A: Standard curve (0, 20, 40, 60,  80, 100 pmole/well of NADH)). Panel B: NAD/NADH levels for three biological samples of  BBa_K1604030 (green) and one negative control BBa_K731201 (blue). The cells were grown as described previously.</p>
 
</div>
 
</div>
Line 100: Line 100:
 
 
 
<div class="row">   
 
<div class="row">   
<div class="7u 12u(narrower) wow bounceInLeft">
+
<div class="7u 12u(narrower) wow bounceInLeft" style="visibility:hidden;">
 
<p style="clear:both" class="image_caption"><span>__Title of the Figure__</span> Lane B samples 2-7 calibration curve (0, 20, 40, 60, 80, 100 pmole/well of NADH). Lane C    samples 2-9 NAD total levels; Lane D samples 2-9 NAD total repeated with a 2 fold concentrated    sample; Lane E NADH only; Lane F NADH only, repeated with a 2 fold concentrated sample. In    lanes C-F the order of the samples is: 2 technical replicates of the negative control, and 2 technical    replicates of each of the 3 biological samples of BBa_K1604031. The plate was read with a Tecan    Infinite M-200 pro instrument at 450 nm. The measurements were taken after 0.5, 1, 2, 3, 4 hours    to allow color development. The data shown are representative of the best measurement at 2    hours.</p>
 
<p style="clear:both" class="image_caption"><span>__Title of the Figure__</span> Lane B samples 2-7 calibration curve (0, 20, 40, 60, 80, 100 pmole/well of NADH). Lane C    samples 2-9 NAD total levels; Lane D samples 2-9 NAD total repeated with a 2 fold concentrated    sample; Lane E NADH only; Lane F NADH only, repeated with a 2 fold concentrated sample. In    lanes C-F the order of the samples is: 2 technical replicates of the negative control, and 2 technical    replicates of each of the 3 biological samples of BBa_K1604031. The plate was read with a Tecan    Infinite M-200 pro instrument at 450 nm. The measurements were taken after 0.5, 1, 2, 3, 4 hours    to allow color development. The data shown are representative of the best measurement at 2    hours.</p>
 
</div>
 
</div>
 
 
<div class="5u 12u(narrower) wow bounceInRight  centered">
+
<div class="5u 12u(narrower) wow bounceInRight  centered" style="visibility:hidden;">
 
<p>
 
<p>
 
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/2/26/Unitn_pics_pncb_wells.jpg" title=""><img src="https://static.igem.org/mediawiki/2015/1/1b/Unitn_pics_pncb_wells_thumb.jpg" alt="" style="width:100%; max-width:500px;"/></a>
 
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/2/26/Unitn_pics_pncb_wells.jpg" title=""><img src="https://static.igem.org/mediawiki/2015/1/1b/Unitn_pics_pncb_wells_thumb.jpg" alt="" style="width:100%; max-width:500px;"/></a>

Revision as of 16:14, 5 September 2015

Results

  • pncB NAD Booster

Introduction to the Results

PncB: nicotinic acid phosphorbosyl-transferase

Our goal was to demonstrate that pncB increased intracellular levels of NAD and thus NADH. We quantified the levels of NAD by a colorimetric test that measures the levels of NAD indirectly by quantifying the concentration of NAD total (NAD + NADH) and NADH only. To make precise quantitation a standard curve with NADH was built. The test provides the ratio of NAD/NADH

NADtotal = Amount of total NAD (NAD+NADH) in unknown sample (pmole) from standard curve.
NADH = Amount of NADH in unknown sample (pmole) from standard curve.

BBa_K1604031 does increase NAD levels by 126% (2.5 fold) and NADH levels by 44% (1.4 fold) when expressed in NEB10β. Although we did see an enhancement in NAD levels, this did not correlate to a proportional boost in NADH levels. We plan in the future to add a NAD reducing enzyme and to give a medium able to enhance the cell metabolism to further increase NADH intracellular levels.